<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7WMMLK" height="0" width="0" style="display:none;visibility:hidden"></iframe>

GC Aesthetics® 您的终生伴侣

提供高品质的产品,让患者在丰胸过程中充满自信和安全感。

在联合王国注册成立

1979

在法国注册成立

1988

收购 Eurosilicone 和 Nagor

2008

与第六代凝胶一起发布

2015

向解决方案提供商发展

2017

实施创新路线图战略

2018

推出 NOA™, Eve 4.0™ 并发布 10年临床研究

2019

推出 PERLE™、HydroCone™ 和 GCA Comfort Plus™ 保修服务

2020

Eurosilicone™和Nagor™品牌正在各个层面向GCA®过渡

2021

推出 FixNip™ NRI

2022

推出 Luna XT™

2023

推出 Puregraft® 和 Healena™ 产品

2024

GCA®的与众不同之处

More than 3 million breast implants placed in the last 10 years, supported by published 10-year clinical data demonstrating compelling safety and effectiveness in aesthetic and reconstructive breast surgery.
Our round and anatomical silicone gel breast implants are backed by long-term peer-reviewed studies evaluating safety, patient satisfaction, and revision rates.
Published clinical evidence includes:

  • Ten-Year Safety Data for Eurosilicone’s Round and Anatomical Silicone Gel Breast Implants (Aesthetic Surgery Journal Open Forum, 2019)
  • Single-Center and Surgeon’s Long-Term (15–19 Years) Patient Satisfaction and Revision Rate of Round Textured Eurosilicone Breast Implants (Aesthetic Surgery Journal, 2021)

This long-term follow-up reinforces our commitment to reliable breast implant performance and evidence-based medical device development.

To design, develop, manufacture, market, and offer best-in-class medical aesthetic solutions that contribute to women’s healthcare, well-being, confidence, empowerment, and overall happiness through safe, reliable breast implant devices placed in the hands of trained and qualified surgeons.

We are committed to advancing standards in breast augmentation and breast reconstruction by combining:

  • Clinical research
  • Rigorous manufacturing processes
  • Regulatory compliance
  • Continuous product innovation

To be the partner of choice for women and surgeons around the world, leading in science, reliability, and innovation in breast implant technology and medical aesthetic solutions.

We aim to continuously support the global surgical community by delivering:

  • Proven long-term safety data
  • Reliable silicone gel implant technology
  • Ongoing scientific collaboration
  • Responsible and transparent medical innovation

Through our Total Breast Care™ approach, we go beyond devices to support the full surgical journey, from consultation to long-term follow-up, helping surgeons improve patient compliance, optimize outcomes, and expand possibilities in both aesthetic and reconstructive procedures. By integrating solutions across pre-, intra-, and post-surgery, we enable more personalized treatments and support enhancement and hybrid procedures with greater confidence.

GC Aesthetics® 新闻

认识 GC Aesthetics® 团队

一个高增长、充满活力的商业环境,为有才能的个人提供了建立伟大事业的机会。

查找 GC Aesthetics®

作为一家在 70 多个国家开展业务的全球性公司,我们对自己的未来充满信心!查找您当地的 GCA® 办事处或经销商。

加入 GC Aesthetics® 。

您是否有兴趣为塑造医疗器械行业的未来做出贡献?加入 GCA® 团队。

免责声明

*本在线 IFU 不取代实际产品包装盒内的官方 IFU。
本信息仅供医疗保健专业人员使用。医疗保健专业人员在决定是否对特定患者使用特定产品时,必须始终依靠其专业临床判断。GC Aesthetics® 不提供医疗建议,并建议医疗保健专业人员在使用任何特定产品进行手术或治疗之前,先接受使用该产品的培训。在使用任何 GC Aesthetics® 产品之前,医疗保健专业人员必须始终参阅包装插页、产品标签和/或使用说明。所提供的信息旨在展示特定产品以及完整的 GC Aesthetics® 产品目录。产品可能不在所有市场销售。本网站包含或提供的所有内容和信息仅供一般参考之用。GC Aesthetics® 对此处所含信息的准确性不作任何陈述,也不承担任何责任,且此类信息如有变更,恕不另行通知。

1.Duteille F 等:Eurosilicone 圆形和解剖型硅凝胶乳房假体的十年安全数据。Aesthet Surg J Open Forum.2019;1(2):ojz012.发表于 2019 Apr 27.